1. Home
  2. PULM vs IPM Comparison

PULM vs IPM Comparison

Compare PULM & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • IPM
  • Stock Information
  • Founded
  • PULM 2003
  • IPM 2005
  • Country
  • PULM United States
  • IPM United States
  • Employees
  • PULM N/A
  • IPM N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • IPM
  • Sector
  • PULM Health Care
  • IPM
  • Exchange
  • PULM Nasdaq
  • IPM NYSE
  • Market Cap
  • PULM 33.2M
  • IPM 27.9M
  • IPO Year
  • PULM N/A
  • IPM N/A
  • Fundamental
  • Price
  • PULM $6.50
  • IPM $1.88
  • Analyst Decision
  • PULM
  • IPM Strong Buy
  • Analyst Count
  • PULM 0
  • IPM 1
  • Target Price
  • PULM N/A
  • IPM $6.00
  • AVG Volume (30 Days)
  • PULM 60.7K
  • IPM 34.3K
  • Earning Date
  • PULM 08-12-2025
  • IPM 08-13-2025
  • Dividend Yield
  • PULM N/A
  • IPM N/A
  • EPS Growth
  • PULM N/A
  • IPM N/A
  • EPS
  • PULM N/A
  • IPM N/A
  • Revenue
  • PULM $1,921,000.00
  • IPM $6,344,746.00
  • Revenue This Year
  • PULM N/A
  • IPM $1,957.49
  • Revenue Next Year
  • PULM $134.88
  • IPM $17.96
  • P/E Ratio
  • PULM N/A
  • IPM N/A
  • Revenue Growth
  • PULM N/A
  • IPM 14.16
  • 52 Week Low
  • PULM $1.78
  • IPM $1.52
  • 52 Week High
  • PULM $10.40
  • IPM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • PULM 39.79
  • IPM N/A
  • Support Level
  • PULM $6.26
  • IPM N/A
  • Resistance Level
  • PULM $6.96
  • IPM N/A
  • Average True Range (ATR)
  • PULM 0.87
  • IPM 0.00
  • MACD
  • PULM -0.12
  • IPM 0.00
  • Stochastic Oscillator
  • PULM 40.16
  • IPM 0.00

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About IPM INTELLIGENT PROTECTION MANAGEMENT

Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.

Share on Social Networks: